Retapamulin Catalog No.:M10666-10 Smiles: CN(C)CCCCC(=O)NC1C=CC(=CC=1)NC(=S)NC(=O)C1C=CC(=CC=1)C(C)(C)C

Smiles: CN(C)CCCCC(=O)NC1C=CC(=CC=1)NC(=S)NC(=O)C1C=CC(=CC=1)C(C)(C)C

AMD 3465 (50 nM) totally blocks CXCL12-induced calcium mobilization

InChi: InChI=1S/C19H23N3O3/c1-2-3-13-22(19(24)20-17-7-5-4-6-8-17)14-15-9-11-16(12-10-15)18(23)21-25/h4-12

LY2606368 selectively binds to chk1

InChiKey: PNMYJIOQIAEYQL-UHFFFAOYSA-N

Retapamulin Catalog No.:M10666-10 Smiles: CN(C)CCCCC(=O)NC1C=CC(=CC=1)NC(=S)NC(=O)C1C=CC(=CC=1)C(C)(C)CRetapamulin, also known as SB 275833, is a newer topical agent of pleuromutilin class approved by the Food and Drug Administration for treatment of impetigo in children. It has been demonstrated to have low potential for the development of antibacterial resistance and a high degree of potency against poly drug resistant Gram positive bacteria found in skin infections including Staphylococcus aureus strains. The drug is safe owing to low systemic